Columns

Since the onset of the Covid-19 pandemic, the biopharmaceutical industry has come together in unprecedented ways to attack the virus, and we have achieved incredible progress in just two years. The industry was able to develop vaccines in just 12 to 18 months, and almost 11 billion doses have been administered worldwide. To put this success in perspective, it typically takes eight to 10 years to develop a vaccine, and the overall success rate is only 5 to 10 percent. But our work is far from over.

University and government venture funds play a much larger role in Japan than they do in Western countries. Yet we see fewer biotechnology startups here compared with, say, the United States, which is home to eight of the top 10 highest-funded ventures. Why?

As a super-aging society with a population of more than 100 million, Japan has the potential to become a destination for healthcare innovation. Its citizens have easy and equal access to quality healthcare services, with pharmaceuticals and medical devices playing important roles in improving quality of life. But there are technological obstacles to overcome. The US medical device industry is leading the effort to develop a data platform in Japan which will enable traceability in healthcare.

The Japanese public is concerned that domestic pharmaceutical companies have yet to launch a single Covid-19 vaccine. Some may argue that this is due to a low rate of vaccine confidence, as is seen in the national tendency to avoid the human papillomavirus (HPV) vaccine, which has, in turn, caused a problem for vaccine development.

Japan faces a very modern problem: its success in delivering universal health coverage and fostering longer life expectancy has led to demographic and social changes that are giving rise to a new set of interconnected healthcare challenges. As the Japanese government moves to reform its healthcare system to address these challenges, new policy approaches will be necessary. With the right approach and policies, Japan can continue to improve the health of its citizens and create a blueprint that aging societies around the world can follow.

One reason that foreign companies choose to invest in Japan is the nation’s high-quality manufacturing and services sectors, as well as its technological prowess and innovative workforce. Maintaining the health of the population—beyond the immediate challenges of Covid-19—is, therefore, critical to the future prosperity of the country and the viability of its business environment.

University and government venture funds play a much larger role in Japan than they do in Western countries. Yet we see fewer biotechnology startups here compared with, say, the United States, which is home to eight of the top 10 highest-funded ventures. Why?

As a super-aging society with a population of more than 100 million, Japan has the potential to become a destination for healthcare innovation. Its citizens have easy and equal access to quality healthcare services, with pharmaceuticals and medical devices playing important roles in improving quality of life. But there are technological obstacles to overcome. The US medical device industry is leading the effort to develop a data platform in Japan which will enable traceability in healthcare.

The Japanese public is concerned that domestic pharmaceutical companies have yet to launch a single Covid-19 vaccine. Some may argue that this is due to a low rate of vaccine confidence, as is seen in the national tendency to avoid the human papillomavirus (HPV) vaccine, which has, in turn, caused a problem for vaccine development.

AI gets a lot of attention these days, but its application to farming is not often in the spotlight. Sagri Co., Ltd. uses AI, machine learning, and mapping technologies to solve social problems. I had the opportunity to talk with CEO Shunsuke Tsuboi about the challenges that agricultural technology startups in Japan face when it comes to funding, as well as the benefits of their technology.

This spring has been a pivotal and exciting time for the ACCJ and the country as a whole. President Victor Osumi shares key events so far in 2025.

As 2024 draws to an end, ACCJ President Victor Osumi looks back on the remarkable achievements of the chamber to foster partnerships, embrace progress, and bridge to the future with excellence.

The 75th anniversary of the ACCJ is an important time to reflect on all we’ve accomplished, how far we’ve come, and how much more there is to achieve. As we find ourselves in a much more complex world the ACCJ must be agile and adapt if we are to continue serving our purpose and our members.

The May meeting of G7 leaders in Hiroshima has focused efforts across the ACCJ to ensure that our voice is heard—and the importance of the chamber reinforced—as Japan and the United States work to coordinate critical policies. Of particular importance are all matters digital.

Looking back at 2022, it was a year of great progress for the American Chamber of Commerce in Japan (ACCJ). I was honored to represent you as president and am humbled to have been reelected for a second term. This year, I look forward to building on our progress, harnessing the energy of our members and leaders who so generously share their time and expertise.

The past few months have been an incredibly dynamic time for Japan and the chamber, as we have continued to be very active in its engagement with the US and Japanese governments through meetings with congressional delegates. Japan laid former Prime Minister Shinzo Abe to rest, and Prime Minister Fumio Kishida announced on September 22 that Japan will fully reopen on October 11.

One of the greatest attractions of the American Chamber of Commerce in Japan (ACCJ) is our myriad activities and the vibrancy of our members. From networking to advocacy to information exchange, the ACCJ is not only the voice of global business in Japan, but a dynamic, rewarding community. The coronavirus pandemic challenged our ability to sustain our energy, but our members are resilient and resourceful. We not only adapted and maintained our inspiring event schedule and connections virtually, but we gained new skills along the way that now allow us to extend our reach and foster greater engagement as the way we interact continues to evolve.

Those movies in which a fighter pilot steps into the role of president and leads everyone through challenging times are always inspirational. ACCJ President Om Prakash, also chief executive of Northrop Grumman Japan, is a US Air Force veteran who was a fighter pilot, test pilot, and vice wing commander of the 82nd Training Wing. In a year filled with opportunities in a transformed world, The ACCJ Journal sat down with Prakash at the Northrop Grumman office to learn more about his background and thoughts on the path ahead.

This is an important year ahead of us. Not only do we welcome a new ambassador but, as our new administrations on both sides of the Pacific get to work together, there are new, exciting, and dynamic opportunities for all of us engaged in commerce between this important alliance of the US and Japan.

As I prepare to pass the baton to Om Prakash as the next president of the American Chamber of Commerce in Japan (ACCJ), I am grateful for what we have all accomplished together this year. He and a newly elected Board of Governors will lead the chamber into 2022 with exciting opportunities for further growth and change.

Live sports and in-person gatherings added to the feeling of normality as chamber events such as the ACCJ Charity Ball, which returned to its in-person format at the Hilton Tokyo in Shinjuku, and the Tokyo and Kansai Shinnenkais kick off the year.

AI is beginning to create content that is sparking questions about ownership. For some time, companies have been using AI-powered tools to give computers the task of writing articles, social media posts, and web copy. Now, AI-powered image-generation engines, such as Stable Diffusion, Midjourney, and the Deep Dream Generator, have hit the mainstream. One day, might DEI be extended to machines?

The intersection of health and technology has become an important part of my life. They say that when you turn 40 your body starts to fall apart. They also say that 40 is the new 20. I say that neither is true, not entirely, but as you age you do have to work harder to stay fit. In this issue of The ACCJ Journal, we embrace the vision, ideas, and creations of those entrepreneurs and companies who are developing solutions to the wellness challenges facing society.

For most of the past two years, we’ve been writing about overcoming the challenges of the pandemic. While the threat of Covid-19 continues, and will likely remain with us for a long time, we’ve adapted and are learning how to function and flourish in a changed world. This includes adjusting how we work. To explore this new reality, we’ve put together four features that focus on various aspects of work and the expectations now shaping the path to success. Plus, there's lots more in the spring 2022 issue of The ACCJ Journal.

Transitions have been a way of life over the past two years. The coronavirus pandemic has forced companies to rethink how they operate, how they manage staff and workflows, and how they communicate. The winds of change have also rustled through the pages of The ACCJ Journal. Since bringing the magazine in house at the start of this year, we’ve made some adjustments and additions that have allowed us to better meet the needs of chamber members and communications. This has been a prelude to a bigger shift.

Most members of the American Chamber of Commerce in Japan (ACCJ) will agree that a greatly missed part of business life over the past two years has been meeting fellow professionals in person. I know that, as a writer and editor, covering the chamber’s events is a highlight of putting together each issue of The ACCJ Journal. It’s been a long road through the pandemic but, thankfully, the ACCJ is once again hosting in-person sessions. The number of these events is limited, but it is wonderful to see that opportunities for networking in the physical world are returning.

Ever since third grade, when my stepfather took me to a store where we bought a rubber stamp emblazoned with Jones Inc., the entrepreneurial spirit has been part of me. This spirit is one reason I enjoy working with so many talented and inspiring businesspeople through the ACCJ to share stories of ideas brought to life and the determination to succeed as an expat.

As we continue building entire issues of The ACCJ Journal around singular themes, this time we take a look at investment—specifically, investing in Japan. From individual entrepreneurs to large organizations, there are many opportunities to be had. There are also many needs to be addressed as the world continues to battle Covid-19 and look beyond the pandemic.

I would like to pause and reflect on the journey we’ve been on and look ahead with positive energy. Over the past several months, talking to leaders of companies large and small, I have found that they are fairly optmistic about the prospects for this year. They are hopeful about moving forward and getting on with business. Of course, there are challenges—supply chains, travel—but there is a feeling that these can be overcome as the ongoing pandemic evolves into a new normal.

One of the strengths of the American Chamber of Commerce in Japan (ACCJ) is the dedication and commitment of our office staff. Their dedication provides the continuity that allows the ACCJ to continue to provide member-focused services and have the ability to adapt to member needs over time. This is especially true in the case of Naoko Kitada, who retired from her position as accounting manager on October 31, after more than 28 years. She joined the ACCJ on October 1, 1993, as assistant accountant.

One of the greatest strengths of our international business community is the varied experiences and skills of our members. I’m proud of the way in which the American Chamber of Commerce in Japan (ACCJ) has transitioned to a virtual environment that allows us to serve the needs of the membership through a robust schedule of events and meetings. But, during the pandemic, tapping into our network for a less formal exchange of ideas and expertise (the way we would during coffee breaks in more normal times) has been a challenge. This month, we’re launching a pilot project to help members discover and connect with other members.